source
- Bristol Myers Squibb reshuffles R&D leadership as chief research officer departs and CMO takes over combined unitBristol Myers Squibb announced a restructuring of its research and development organization, merging the separate research and development divisions into a single unit. The new combined R&D unit w…
- Senate debate looms over Heidi Overton’s potential FDA nominationThe article raises the question of whether Heidi Overton will be nominated to head the FDA and how the Senate might respond. It notes that a committee chair typically schedules a confirmation vote…